The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis

Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis

October 1, 2013 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Foundation News
The Foundation has awarded 101 Disease Targeted Research Initiative grants.

You Might Also Like
  • Rheumatology Research Foundation President Aims to Make Specialty More Unified
  • Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis
  • Rheumatology Research Foundation Expands Studies in Rheumatic Diseases Through Career Support
Explore This Issue
October 2013
Also By This Author
  • Rheumatology Research Foundation Grant Supports Medical School Curriculum Study

Advancing Targeted Research

As one important step in achieving its mission to advance research and training in rheumatology to help improve the health of people with rheumatic diseases, the Rheumatology Research Foundation launched its Disease Targeted Research Initiative seven years ago. In that span, the Foundation has awarded 101 pilot and innovative research grants, totaling $43.2 million, to investigators exploring aspects of rheumatoid arthritis (RA) and other forms of inflammatory disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

On June 21–23 at the Fairmont Hotel in Dallas, the Rheumatology Research Foundation gathered a group of these investigators to present their latest findings. In addition to poster presentations, 22 investigators from institutions around the U.S. had the opportunity to engage in collaborative discussions surrounding inflammatory disease. Live sessions included presentations on drug clinical trial updates, cardiovascular risk in RA, epigenetics, outcome measures and quality, disease pathogenesis, pathways of inflammation, and other topics.

Based on the quality of the research presented at the meeting and the positive response from many attendees, the Investigators Meeting was “an unqualified success,” says David Daikh, MD, PhD, the Foundation’s President. “The relatively small and intimate meeting provided investigators focused on a single and important topic—inflammatory arthritis—the opportunity to share and discuss new ideas.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The research presented at the Dallas meeting will not just be of interest to rheumatologists, but will also resonate with the patient community, as it may generate more effective treatments and preventive measures in RA, says Dr. Daikh. “For example, new understanding about the role of gingivitis in disease activity in rheumatoid arthritis has important implications in developing new ways of preventing disease and decreasing disease activity,” he says. “Similarly, results from a new clinical trial funded by the Foundation may show how to identify the development of cardiovascular disease in patients with inflammatory arthritis in time to initiate preventive therapy.”

Even though the Disease Targeted Research Initiative is only a few years old, the results of the Foundation’s commitment to these investigators already reveal important data that will one day help rheumatologists and their patients better tackle these diseases, says David Karp, MD, PhD, the Foundation’s Vice President. Success breeds success, with exciting findings sparking further studies, he adds.

“These meetings have become a highlight of the program, as the top researchers in the field get a chance to share their findings and discuss new projects. The meetings are small, and allow for a lot of informal discussion and cross-fertilization of ideas. Even though the program is still relatively young, we have seen ideas for newly funded projects spring from previous meetings,” says Dr. Karp.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College Tagged With: foundation, Inflammatory arthritis, Research, Rheumatoid arthritis, rheumatologyIssue: October 2013

You Might Also Like:
  • Rheumatology Research Foundation President Aims to Make Specialty More Unified
  • Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis
  • Rheumatology Research Foundation Expands Studies in Rheumatic Diseases Through Career Support
  • Rheumatology Research Foundation Backs Need to Accelerate New Medicines for Lupus

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.